DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
Németh G, Laszlovszky I, Czobor P. et al.
Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: A randomised, double-blind, controlled trial.
Lancet 2017;
389: 1103-1113
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.